Bgm (BGM) Total Current Liabilities (2019 - 2025)
Bgm (BGM) posted quarterly Total Current Liabilities of $41.6 million for Q3 2025, up 373.99% year-over-year from $8.8 million in Q3 2024, and up 76.37% quarter-over-quarter from $23.6 million in Q1 2025.
Bgm (BGM) Total Current Liabilities (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Total Current Liabilities for 7 consecutive years, with $41.6 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Total Current Liabilities rose 373.99% year-over-year to $41.6 million; the TTM figure through Sep 2025 stood at $41.6 million (up 373.99% YoY), while the FY2025 annual figure was $41.6 million, up 373.99% from the prior year.
- Total Current Liabilities improved to $41.6 million in Q3 2025 per BGM's latest filing, from $23.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $22174.7 billion in Q1 2022 and bottomed at $4.7 million in Q1 2024.
- Historically, Total Current Liabilities has averaged $3484.2 billion across 5 years, with a median of $18.2 million in 2021.
- Annual changes were most pronounced in 2024 — Total Current Liabilities sank 100.0% — and 2025, when it surged 398.71%.
- Bgm's Total Current Liabilities stood at $18.2 million in 2021, then plunged by 49.49% to $9.2 million in 2022, then dropped by 27.45% to $6.7 million in 2023, then jumped by 31.77% to $8.8 million in 2024, then soared by 373.99% to $41.6 million in 2025.
- Business Quant data shows BGM's Total Current Liabilities at $41.6 million in Q3 2025, $23.6 million in Q1 2025, and $8.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | 41.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 41.60 Mn |
| Mar 31, 2025 | 23.59 Mn |
| Sep 30, 2024 | 8.78 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Sep 30, 2023 | 6.66 Mn |
| Mar 31, 2023 | 9,183.23 Bn |
| Sep 30, 2022 | 9.18 Mn |
| Mar 31, 2022 | 22,174.68 Bn |
| Sep 30, 2021 | 18.17 Mn |
| Sep 30, 2020 | 18.42 Mn |
| Sep 30, 2019 | 11.66 Mn |